Related Experiment Video
Updated: Aug 11, 2026

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
Acetylation of Stat1 modulates NF-kappaB activity
Oliver H Krämer1, Daniela Baus, Shirley K Knauer
1Georg-Speyer-Haus, D-60596 Frankfurt, Germany.
Abstract:
Acetylation of signaling molecules can lead to apoptosis or differentiation of carcinoma cells. The molecular mechanisms underlying these processes and the biological role of enzymes mediating the transfer or removal of an acetyl-group are currently under intense investigation. Our study shows that Stat1 is an acetylated protein. Stat1 acetylation depends on the balance between Stat1-associated histone deacetylases (HDACs) and histone acetyltransferases (HATs) such as CBP. Remarkably both inhibitors of HDACs and the cytokine interferon alpha alter this equilibrium and induce Stat1 acetylation. The analysis of Stat1 mutants reveals Lys 410 and Lys 413 as acetylation sites. Experiments with Stat1 mutants mimicking either constitutively acetylated or nonacetylated states show that only acetylated Stat1 is able to interact with NF-kappaB p65. As a consequence, p65 DNA binding, nuclear localization, and expression of anti-apoptotic NF-kappaB target genes decrease. These findings show how the acetylation of Stat1 regulates NF-kappaB activity and thus ultimately apoptosis.
Insights
Stat1 protein acetylation, regulated by histone deacetylases (HDACs) and histone acetyltransferases (HATs), impacts carcinoma cell apoptosis. Acetylated Stat1 inhibits NF-kappaB p65 activity, decreasing anti-apoptotic gene expression.
Area of Science:
- Molecular Biology
- Cellular Biology
- Biochemistry
Background:
- Acetylation of signaling molecules influences carcinoma cell apoptosis and differentiation.
- The roles of histone deacetylases (HDACs) and histone acetyltransferases (HATs) in these processes are under active investigation.
Purpose of the Study:
- To investigate the acetylation status of Signal Transducer and Activator of Transcription 1 (Stat1).
- To elucidate the role of Stat1 acetylation in regulating the activity of Nuclear Factor kappa B (NF-kappaB).
Main Methods:
- Analysis of Stat1 acetylation using inhibitors of HDACs and HATs, and interferon alpha.
- Site-directed mutagenesis to identify Stat1 acetylation sites (Lys 410 and Lys 413).
- Co-immunoprecipitation assays to assess Stat1 interaction with NF-kappaB p65.
Main Results:
- Stat1 is identified as an acetylated protein, with acetylation levels modulated by the balance of HDACs and HATs (e.g., CBP).
- Inhibitors of HDACs and interferon alpha induce Stat1 acetylation.
- Acetylated Stat1 fails to interact with NF-kappaB p65, leading to reduced p65 DNA binding, nuclear localization, and expression of anti-apoptotic target genes.
Conclusions:
- Stat1 acetylation is a critical regulatory mechanism controlling NF-kappaB activity.
- Modulation of Stat1 acetylation influences the expression of NF-kappaB target genes, thereby impacting apoptosis in carcinoma cells.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The JAK-STAT Signaling Pathway
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Co-activators and Co-repressors
Regulation of Nuclear Protein Sorting
Spreading of Chromatin Modifications
Writers
The writer is an enzyme that can...

